Full Text View
Tabular View
No Study Results Posted
Related Studies
The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial (SOLID-TIMI 52)
This study is ongoing, but not recruiting participants.
Study NCT01000727   Information provided by GlaxoSmithKline

First Received on October 22, 2009.   Last Updated on October 25, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atherosclerosis
Acute Coronary Syndrome
Cardiovascular Disease
Coronary Heart Disease
Additional conditions recognized in this trial
Cardiovascular Diseases
Coronary Artery Disease
Coronary Disease
Heart Diseases
Myocardial Infarction
Myocardial Ischemia
More general conditions related to this trial
Angina Pectoris
Arterial Occlusive Diseases
Arteriosclerosis
Chest Pain
Pain
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
Darapladib 160 mg
Placebo
Sponsors listed in this trial
GlaxoSmithKline
The TIMI Study Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services